Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain … – Xconomy
Xconomy |
Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain …
Xconomy Gene therapy developer Tocagen is preparing an initial public stock offering to finance clinical trials of its experimental treatment for a form of brain c. Tocagen seeks $86M IPO to fund cancer gene therapy trial …FierceBiotech Gene Therapy Developer Tocagen Files for $86M IPO | GENGenetic Engineering & Biotechnology News (press release) Tocagen readies IPO | Seeking AlphaSeeking Alpha |
Curetoday.com |
Debunking the Myths of Stem Cell Donation
Curetoday.com At the time, there were only about 3,000 potential stem cell donors in Germany. None of Mechtild’s siblings was a match, so she needed an unrelated donor. Unfortunately, that did not happen in time for her. But her death was not in vain. DKMS has … |